Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension
- PMID: 26300023
- PMCID: PMC4698220
- DOI: 10.1016/j.jpainsymman.2015.07.012
Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension
Abstract
Context: While assessing symptom severity is an important component of evaluating symptoms, understanding those symptoms that interfere with patients' lives is also key. Pulmonary arterial hypertension (PAH) is a chronic disease resulting in right heart failure and increased mortality. Patients with PAH experience multiple symptoms but we do not know which symptoms and to what extent their symptoms interfere with daily life.
Objectives: To: (1) describe the prevalence of those symptoms that interfere with life; (2) describe the severity of symptom interference; and (3) determine those sociodemographic and clinical characteristics and interfering symptoms associated with health-related quality of life (HRQOL) in patients with PAH.
Methods: A convenience sample of 191 patients with PAH completed a sociodemographic form, the Pulmonary Arterial Hypertension Symptom Interference Scale (PAHSIS) and the Medical Outcomes Survey Short Form-36 to measure HRQOL. Hierarchical multiple linear regression was used to analyze demographic and medical characteristics along with symptom interference from the PAHSIS as predictors of HRQOL from the composite mental and physical health summary scores of the Short Form-36.
Results: The most interfering symptoms reported were fatigue, shortness of breath with exertion, and difficulty sleeping. Age, gender, functional class, oxygen use, fatigue, dizziness, and Raynaud phenomenon were associated with the HRQOL physical health summary scores. The symptoms fatigue and SOB while lying down were associated with the HRQOL mental health summary scores.
Conclusion: Patients with PAH are experiencing multiple symptoms that are interfering with their HRQOL and ability to function.
Keywords: Symptoms; interference; pulmonary arterial hypertension; quality of life.
Copyright © 2016 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study.Eur J Cardiovasc Nurs. 2012 Mar;11(1):51-61. doi: 10.1177/1474515111429649. Epub 2012 Jan 11. Eur J Cardiovasc Nurs. 2012. PMID: 22357779
-
Symptom Prevalence, Symptom Severity, and Health-Related Quality of Life Among Young, Middle, and Older Adults With Pulmonary Arterial Hypertension.Am J Hosp Palliat Care. 2016 Apr;33(3):214-21. doi: 10.1177/1049909114554079. Epub 2014 Oct 7. Am J Hosp Palliat Care. 2016. PMID: 25294227
-
Sleep disturbance, symptoms, psychological distress, and health-related quality of life in pulmonary arterial hypertension.Eur J Cardiovasc Nurs. 2015 Oct;14(5):423-30. doi: 10.1177/1474515114537951. Epub 2014 May 27. Eur J Cardiovasc Nurs. 2015. PMID: 24867878
-
Pulmonary arterial hypertension: the burden of disease and impact on quality of life.Eur Respir Rev. 2015 Dec;24(138):621-9. doi: 10.1183/16000617.0063-2015. Eur Respir Rev. 2015. PMID: 26621976 Free PMC article. Review.
-
Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis.PLoS Med. 2022 Apr 6;19(4):e1003954. doi: 10.1371/journal.pmed.1003954. eCollection 2022 Apr. PLoS Med. 2022. PMID: 35385471 Free PMC article.
Cited by
-
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient Population.Cancer Med. 2025 Mar;14(5):e70682. doi: 10.1002/cam4.70682. Cancer Med. 2025. PMID: 40052556 Free PMC article.
-
Does All Social Support Work? Examining the Mechanisms of Patient-Reported Symptom Interference after Esophagectomy Affecting Life Satisfaction.Patient Prefer Adherence. 2024 Aug 19;18:1755-1766. doi: 10.2147/PPA.S472858. eCollection 2024. Patient Prefer Adherence. 2024. PMID: 39184146 Free PMC article.
-
Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and former users of oral selexipag.J Patient Rep Outcomes. 2023 Dec 18;7(1):134. doi: 10.1186/s41687-023-00673-w. J Patient Rep Outcomes. 2023. PMID: 38108945 Free PMC article.
-
Implantable system for treprostinil: a real-world patient experience study.Pulm Circ. 2020 Apr 22;10(2):2045894020907881. doi: 10.1177/2045894020907881. eCollection 2020 Apr-Jun. Pulm Circ. 2020. PMID: 32363029 Free PMC article.
-
Relationships that perceived barriers to physical activity have with functional capacity and quality of life in patients with pulmonary hypertension.J Bras Pneumol. 2025 Mar 31;51(1):e20240195. doi: 10.36416/1806-3756/e20240195. eCollection 2025. J Bras Pneumol. 2025. PMID: 40172409 Free PMC article.
References
-
- McGoon MD, Benza RL, Escribano-Subias P, et al. Pulmonary arterial hypertensionepidemiology and registries. J Am Coll Cardiol. 2013;62(25 Suppl):D51–59. - PubMed
-
- Lau EM, Humbert M, Celermajer DS. Early detection of pulmonary arterial hypertension. Nat Rev Cardiol. 2015;12:143–155. - PubMed
-
- Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2009;30:2493–2537. - PubMed
-
- Benza RL, Miller DP, Barst RJ, et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the reveal registry. Chest. 2012;142:448–456. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical